Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Neringa Zadeikis"'
Publikováno v:
Clinical Therapeutics. 27:1251-1259
Objective: This subgroup analysis sought to determine the efficacy and tolerability of a 5-day regimen of levofloxacin 750 mg/d compared with a 10-day regimen of levofloxacin 500 mg/d in the treatment of community-acquired pneumonia (CAP) in elderly
Autor:
R F Grossman, K Walker, Neringa Zadeikis, Alan M. Tennenberg, Alan C. Fisher, Fernando J. Martinez, Mary Ambruzs
Publikováno v:
European Respiratory Journal. 25:1001-1010
This is the first prospective clinical trial in which patients with acute bacterial exacerbation of chronic bronchitis have been stratified by degree of underlying illness. Uncomplicated patients were randomised to levofloxacin 750 mg once daily (q.d
Autor:
Gary Milkovich, Neringa Zadeikis, Jim Xiang, Thomas M. File, Mohammed M. Khashab, Alan M. Tennenberg
Publikováno v:
Current Medical Research and Opinion. 20:1473-1481
To evaluate the time to symptom resolution and i.v.-to-p.o. transition in community-acquired pneumonia (CAP) patients treated with 750 mg or 500 mg levofloxacin.A retrospective, subset analysis of a multicenter, randomized, double-blind, controlled t
Autor:
William H. Olson, Alan M. Tennenberg, Mohammed M. Khashab, Victor L. Yu, Janet E. Stout, Richard N. Greenberg, Neringa Zadeikis
Publikováno v:
Chest. 125:2135-2139
Background: Although fluoroquinolones possess excellent in vitro activity against Legionella, few large-scale clinical trials have examined their efficacy in the treatment of Legionnaires disease. Even fewer studies have applied rigorous criteria for
Autor:
James B. Kahn, Alan M. Tennenberg, Lala M. Dunbar, Mohammed M. Khashab, Neringa Zadeikis, Jim Xiang
Publikováno v:
Current Medical Research and Opinion. 20:555-563
Current recommended durations for treatment of atypical community-acquired pneumonia (CAP) range from 10 to 21 days. However, antibiotics such as the fluoroquinolones may allow for effective, short-course regimens.This study evaluated the efficacy of
Autor:
Anthony S. Ramage, Alan M. Tennenberg, Shu Chen Wu, Andrew F. Shorr, Marin H. Kollef, William L. Jackson, Neringa Zadeikis
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 40
Ventilator-associated pneumonia (VAP) remains a significant challenge in critical care. We conducted a secondary analysis of a multicenter, prospective, randomized trial comparing levofloxacin (750 mg iv q24h) with imipenem-cilastatin (500-1000 mg iv
Autor:
William Bundrick, William M. Schiff, Paul Ray, Sean P Heron, James B. Kahn, Alan M. Tennenberg, Barbara A. Wiesinger, Pamela A Wright, Shu-Chen Wu, Neringa Zadeikis
Publikováno v:
Urology. 62(3)
Objectives To compare the safety and efficacy of levofloxacin with that of ciprofloxacin for the treatment of chronic bacterial prostatitis. Methods In a multicenter, double-blind, active-control trial, 377 men with a history of chronic bacterial pro
Autor:
Leon G. Smith, Michael P. Habib, Mohammed M. Khashab, Lala M. Dunbar, Neringa Zadeikis, Barbara A. Wiesinger, Jim Xiang, James B. Kahn, Alan M. Tennenberg, Richard G. Wunderink
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 37(6)
Levofloxacin demonstrates concentration-dependent bactericidal activity most closely related to the pharmacodynamic parameters of the ratio of area under the concentration-time curve (AUC) to minimum inhibitory concentration (MIC) and the ratio of pe
Publikováno v:
Journal of Urology. 173:30-30
Publikováno v:
Chest. 126:848S